We are live on ! Find out more
TECX

Tectonic Therapeutic

89 hedge funds and large institutions have $481M invested in Tectonic Therapeutic in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 19

43% more capital invested

Capital invested by funds: $337M → $481M (+$144M)

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

5% more funds holding

Funds holding: 8589 (+4)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more ownership

Funds ownership: 6.29%6.29% (+0%)

Holders
89
Holders Change
+4
Holders Change %
+4.71%
% of All Funds
1.75%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
20
Increased
32
Reduced
19
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MWNA
26
Marshall Wace North America
New York
$3.89M +$3.1M +16,091 New
WP
27
Woodline Partners
California
$3.86M +$3.08M +15,992 New
Wellington Management Group
28
Wellington Management Group
Massachusetts
$3.47M +$10.2K +53 +0.4%
UBS AM
29
UBS AM
Illinois
$3.43M +$375K +1,947 +16%
KCM
30
Kennedy Capital Management
Missouri
$3.3M +$2.63M +13,645 New
Millennium Management
31
Millennium Management
New York
$3.25M +$2.59M +13,448 New
Invesco
32
Invesco
Georgia
$2.88M
N
33
Nuveen
North Carolina
$2.84M -$305K -1,584 -12%
Charles Schwab
34
Charles Schwab
California
$2.65M +$7.71K +40 +0.4%
Ameriprise
35
Ameriprise
Minnesota
$2.07M +$66.7K +346 +4%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.92M +$122K +631 +9%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$1.87M +$347K +1,798 +30%
PHP
38
Parkman Healthcare Partners
Connecticut
$1.81M +$1.45M +7,500 New
Goldman Sachs
39
Goldman Sachs
New York
$1.7M -$103K -534 -7%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$1.61M +$1.24M +6,445 +2,790%
TCM
41
Tekla Capital Management
Massachusetts
$1.51M +$879K +4,559 +271%
Morgan Stanley
42
Morgan Stanley
New York
$1.27M -$479K -2,486 -32%
Balyasny Asset Management
43
Balyasny Asset Management
Illinois
$1.2M +$956K +4,957 New
Squarepoint
44
Squarepoint
New York
$1.01M +$348K +1,805 +76%
Swiss National Bank
45
Swiss National Bank
Switzerland
$854K +$44.9K +233 +7%
Two Sigma Investments
46
Two Sigma Investments
New York
$755K +$602K +3,125 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$752K +$600K +3,113 New
SIM
48
Spark Investment Management
New York
$734K +$586K +3,040 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$646K
Neuberger Berman Group
50
Neuberger Berman Group
New York
$604K +$482K +2,500 New

TECX Hedge Fund Activity: Q4 2019 in Review

89 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2019, worth a combined $481M — up 43% from $337M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TECX positions and 16 closed out — a net gain of 4 holders — while 32 added to existing stakes and 19 trimmed.

The largest buyer was Deerfield Management, adding an estimated $10.7M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $11.1M sold.

  • 89 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2019, up from 85 in Q3 2019.
  • Funds reported $481M of Tectonic Therapeutic stock for Q4 2019, up 43% quarter-over-quarter.
  • 20 funds opened new Tectonic Therapeutic positions in Q4 2019 and 16 closed out, a net change of +4 holders.
  • The largest Tectonic Therapeutic buyer in Q4 2019 was Deerfield Management, an estimated $10.7M added.
  • The largest Tectonic Therapeutic seller in Q4 2019 was PFM Health Sciences, an estimated $11.1M sold.

Based on aggregated 13F filings for Q4 2019.